Location History:
- Aachen, DE (2017)
- Antwerp, BE (2019)
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Stephanie Kapelski
Introduction
Stephanie Kapelski is a prominent inventor based in Antwerp, Belgium. She has made significant strides in the field of biotechnology, particularly in developing novel anti-parasitic treatments. With a total of 2 patents to her name, her work is paving the way for advancements in medical therapies against parasitic diseases.
Latest Patents
Kapelski's latest patents include groundbreaking technologies aimed at combating parasitic infections. One of her notable inventions is the development of anti-parasitic complexes. This technology involves recombinant fusion proteins that serve as potential drugs for humans and animals against parasites of the phylum Apicomplexa. The complexes consist of at least one component A, which binds to cellular surface structures on the parasite, and component B, which possesses anti-parasitic activity.
Another significant patent is focused on anti-plasmodium parasite antibodies. This invention pertains to human antibodies specifically targeting the malaria parasite. The antibodies exhibit high affinity for merozoite surface protein 10 (MSP10) and are designed to inhibit the reinvasion of merozoites into erythrocytes, effectively neutralizing parasitic multiplication.
Career Highlights
Stephanie Kapelski is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V., a leading research organization in applied sciences. Her work at this institution has allowed her to contribute to innovative solutions in the fight against parasitic diseases.
Collaborations
Throughout her career, Kapelski has collaborated with esteemed colleagues, including Rolf Fendel and Stefan Barth. These partnerships have enhanced her research and expanded the impact of her inventions in the scientific community.
Conclusion
Stephanie Kapelski's contributions to the field of biotechnology are noteworthy, particularly in the development of anti-parasitic therapies. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving health outcomes.